303 related articles for article (PubMed ID: 9393309)
21. [Treatment of isolated nocturnal enuresis: alarm or desmopressin?].
Faraj G; Cochat P; Cavailles ML; Chevallier C
Arch Pediatr; 1999 Mar; 6(3):271-4. PubMed ID: 10191892
[TBL] [Abstract][Full Text] [Related]
22. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.
Rittig S; Schaumburg HL; Siggaard C; Schmidt F; Djurhuus JC
J Urol; 2008 Jun; 179(6):2389-95. PubMed ID: 18433780
[TBL] [Abstract][Full Text] [Related]
23. Diuretic treatment of nocturnal enuresis: preliminary results of an open pilot study.
Nevéus T; Johansson E; Hansson S
J Urol; 2004 Jun; 171(6 Pt 2):2584-5. PubMed ID: 15118424
[TBL] [Abstract][Full Text] [Related]
24. Bladder dysfunction in children with refractory monosymptomatic primary nocturnal enuresis.
Yeung CK; Chiu HN; Sit FK
J Urol; 1999 Sep; 162(3 Pt 2):1049-54; discussion 1054-5. PubMed ID: 10458430
[TBL] [Abstract][Full Text] [Related]
25. Desmopressin in the treatment of severe nocturnal enuresis in adolescents--a 7-year follow-up study.
Läckgren G; Lilja B; Nevèus T; Stenberg A
Br J Urol; 1998 May; 81 Suppl 3():17-23. PubMed ID: 9634013
[TBL] [Abstract][Full Text] [Related]
26. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
[TBL] [Abstract][Full Text] [Related]
27. The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation.
Wolfish NM; Barkin J; Gorodzinsky F; Schwarz R
Scand J Urol Nephrol; 2003; 37(1):22-7. PubMed ID: 12745738
[TBL] [Abstract][Full Text] [Related]
28. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
[TBL] [Abstract][Full Text] [Related]
30. The relationship between desmopressin treatment and voiding pattern in children.
Hvistendahl GM; Rawashdeh YF; Kamperis K; Hansen MN; Rittig S; Djurhuus JC
BJU Int; 2002 Jun; 89(9):917-22. PubMed ID: 12010240
[TBL] [Abstract][Full Text] [Related]
31. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
Schulman SL; Stokes A; Salzman PM
J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804
[TBL] [Abstract][Full Text] [Related]
33. Evidence against a synergistic effect of desmopressin with conditioning in the treatment of nocturnal enuresis.
Gibb S; Nolan T; South M; Noad L; Bates G; Vidmar S
J Pediatr; 2004 Mar; 144(3):351-7. PubMed ID: 15001941
[TBL] [Abstract][Full Text] [Related]
34. The influence of urine osmolality and other easily detected parameters on the response to desmopressin in the management of monosymptomatic nocturnal enuresis in children.
Sözübir S; Ergun G; Celik A; Ulman I; Avanoglu A
Minerva Urol Nefrol; 2006 Jun; 58(2):207-12. PubMed ID: 16767075
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group.
Hjälmås K; Hanson E; Hellström AL; Kruse S; Sillén U
Br J Urol; 1998 Nov; 82(5):704-9. PubMed ID: 9839587
[TBL] [Abstract][Full Text] [Related]
36. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis.
Eller DA; Homsy YL; Austin PF; Tanguay S; Cantor A
Scand J Urol Nephrol Suppl; 1997; 183():41-5. PubMed ID: 9165605
[TBL] [Abstract][Full Text] [Related]
37. The effect of alarm treatment on the functional bladder capacity in children with monosymptomatic nocturnal enuresis.
Hvistendahl GM; Kamperis K; Rawashdeh YF; Rittig S; Djurhuus JC
J Urol; 2004 Jun; 171(6 Pt 2):2611-4. PubMed ID: 15118431
[TBL] [Abstract][Full Text] [Related]
38. Primary nocturnal enuresis and desmopressin treatment: do psychosocial factors affect outcome?
Dittmann RW; Wolter S
Eur Child Adolesc Psychiatry; 1996 Jun; 5(2):101-9. PubMed ID: 8814416
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound bladder measurements in patients with primary nocturnal enuresis: a urodynamic and treatment outcome correlation.
Yeung CK; Sreedhar B; Leung VT; Metreweli C
J Urol; 2004 Jun; 171(6 Pt 2):2589-94. PubMed ID: 15118426
[TBL] [Abstract][Full Text] [Related]
40. Evidence of reduced bladder capacity during nighttime in children with monosymptomatic nocturnal enuresis.
Borg B; Kamperis K; Olsen LH; Rittig S
J Pediatr Urol; 2018 Apr; 14(2):160.e1-160.e6. PubMed ID: 29174376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
